FFO
DNA icon

Fortitude Family Office’s Ginkgo Bioworks DNA Stock Holding History

Fortitude Family Office’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$629 Sell
49
-33
-40% -$269 ﹤0.01% 2351
2026
Q2 		$813 Buy
+82
New +$686 ﹤0.01% 1827
2026
Q1 		– Sell
-72
Closed -$598 – 1934
2025
Q4 		$598 Hold
72
– – ﹤0.01% 1637
2025
Q3 		$1.05K Hold
72
– – ﹤0.01% 1526
2025
Q2 		$810 Buy
+72
New +$558 ﹤0.01% 1604

Other funds holding DNA

QFMHK
Q Fund Management (Hong Kong) Hong Kong $104M AUM 789.73% 1-Year Est. Return
BSWM
Boston Standard Wealth Management Winchester, Massachusetts $696M AUM 8.98% 1-Year Est. Return
TWM
TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $320M AUM 23.25% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Fortitude Family Office's DNA Position: Q3 2026 in Review

Fortitude Family Office reduced its Ginkgo Bioworks (DNA) stake by 40% in Q3 2026, selling an estimated $269 and leaving 49 shares worth $629. The position accounts for ﹤0.01% of the portfolio, ranked #2351.

Fortitude Family Office first reported a position in DNA in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.05K in Q3 2025. 10 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Fortitude Family Office held 49 shares of Ginkgo Bioworks worth $629 as of Q3 2026.
  • Fortitude Family Office sold 33 Ginkgo Bioworks shares in Q3 2026, an estimated $269.
  • Ginkgo Bioworks made up ﹤0.01% of Fortitude Family Office's portfolio in Q3 2026, its #2351 holding.
  • Fortitude Family Office first reported a position in Ginkgo Bioworks in Q2 2025 and has held it in 5 quarters since.
  • Fortitude Family Office's Ginkgo Bioworks position peaked at $1.05K in Q3 2025.
  • 10 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.